Integrating Medical Devices into Pharmacovigilance Portfolios
In her latest article for IPI, Qinecsa President, Humaira Qureshi discussed the practical challenges of integrating medical devices into pharmacovigilance portfolios, the obligations of device manufacturers, how to navigate the European Medical Device Regulation, maintaining effective post-market surveillance and managing the life cycle of a medical device. Understanding medical device regulations is essential for pharmacovigilance […]
Shaping the Future of Clinical Research Technology
A head of our first exhibition at the DIA Global Annual Meeting, taking place in San Diego from June 16th-20th, Qinecsa spoke with Outsourcing-Pharma about our latest breakthrough in clinical research technology, how it addresses the current challenges in the industry, and the major trends that will shape the future of pharmaceuticals. You can read the […]
Embracing a new future-ready pharmacovigilance ecosystem
Following her attendance at DIA Europe 2024, Humaira Qureshi, President of Qinecsa Solutions, spoke with PharmaPhorum about the transforming pharmacovigilance landscape, the potential barriers and how organizations can embrace a new future-ready pharmacovigilance ecosystem. “This offers an opportunity to embrace novel technologies, aligned with culture and processes, to demonstrate how pharmacovigilance (PV) can save time, […]
PV Insights Network Benchmarking Report: The dynamics of drug safety in small pharma, biotech, and medical devices
Drug safety is critical to protect patients and consumers exposed to pharmaceutical development and commercialized drugs. Although the principal framework for Drug Safety and PV operation is similar for all small pharma, biotech, and medical device companies, organized collection and analysis of this segment’s PV profile and process is limited. Efficient and effective drug safety […]
PV Insights Network White Paper: Key challenges to address pharmacovigilance needs
Drug safety leaders speak There are thousands of small pharma and biotech companies around the world. Yet when it comes to drug safety, these organizations often struggle to source specialist support that addresses the unique challenges they face. From April to June 2023, we undertook a roundtable series ‘Drug safety in small pharma and biotech’ […]
Qinecsa Company Brochure
Qinecsa specializes in technology-led, end-to-end pharmacovigilance solutions, built on over 20 years of heritage expertise. As a trusted global partner, we combine best-in-class technology with scientific know-how to connect life science companies with the right safety solutions. With a deep understanding of pharmacovigilance challenges, we have developed industry-leading, comprehensive solutions for capturing, managing, and evaluating […]
Reportum Pharmacovigilance Platform
Reportum is a unified adverse event platform managing both digital and analogue intake from all sources. It offers a digital-first experience for consumers and healthcare professionals, as well as expert pharma users in call centers, PSPs, sales organizations and more. With automated ingestion of PV forms such as CIOMS and MedWatch, it provides a single, […]
Quality & Compliance
Qinecsa provide quality and compliance services to support clients in audit and inspection readiness, SOP writing, data privacy adherence, pharmacovigilance training, PSMF maintenance and CAPA management.
End-to-End Case Management
Qinecsa is a leading global provider of end-to-end pharmacovigilance solutions. Our team of pharmacovigilance specialists leverage technology solutions to deliver all aspects of global case management for both clinical and post-marketing products.
Signal & Risk Management
Qinecsa provides tailored signal detection and risk management services for clinical and commercial products, including associated benefit-risk management activities. With diverse therapeutic expertise and industry-leading technology, our team support the breadth and depth of signal evaluation and risk management obligations.
